Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment P Li, JX Shan, XH Chen, D Zhang, LP Su, XY Huang, BQ Yu, QM Zhi, ... Cell research 25 (5), 588-603, 2015 | 169 | 2015 |
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2 D Bedognetti, TL Spivey, Y Zhao, L Uccellini, S Tomei, ME Dudley, ... British journal of cancer 109 (9), 2412-2423, 2013 | 146 | 2013 |
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis W Hendrickx, I Simeone, S Anjum, Y Mokrab, F Bertucci, P Finetti, ... Oncoimmunology 6 (2), e1253654, 2017 | 145 | 2017 |
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients ML Ascierto, MO Idowu, Y Zhao, H Khalak, KK Payne, XY Wang, ... Journal of translational medicine 11, 1-11, 2013 | 117 | 2013 |
Future perspectives in melanoma research: Meeting report from the “Melanoma Bridge”. Napoli, December 1st–4th 2015 PA Ascierto, S Agarwala, G Botti, A Cesano, G Ciliberto, MA Davies, ... Journal of translational medicine 14, 1-25, 2016 | 95 | 2016 |
IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes D Murtas, D Maric, V De Giorgi, J Reinboth, A Worschech, P Fetsch, ... British journal of cancer 109 (1), 76-82, 2013 | 67 | 2013 |
Cutaneous melanoma classification: the importance of high-throughput genomic technologies C Scatena, D Murtas, S Tomei Frontiers in oncology 11, 635488, 2021 | 61 | 2021 |
Detection of the BRAF V600E mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve … I Marchetti, G Iervasi, CM Mazzanti, F Lessi, S Tomei, AG Naccarato, ... Thyroid 22 (3), 292-298, 2012 | 59 | 2012 |
The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management F Panebianco, C Mazzanti, S Tomei, P Aretini, S Franceschi, F Lessi, ... Bmc Cancer 15, 1-11, 2015 | 57 | 2015 |
Melanoma NOS1 expression promotes dysfunctional IFN signaling Q Liu, S Tomei, ML Ascierto, V De Giorgi, D Bedognetti, C Dai, L Uccellini, ... The Journal of clinical investigation 124 (5), 2147-2159, 2014 | 50 | 2014 |
VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma F Lessi, CM Mazzanti, S Tomei, C Di Cristofano, A Minervini, M Menicagli, ... Medical Oncology 31, 1-7, 2014 | 43 | 2014 |
IRF5 gene polymorphisms in melanoma L Uccellini, V De Giorgi, Y Zhao, B Tumaini, N Erdenebileg, ME Dudley, ... Journal of translational medicine 10, 1-8, 2012 | 40 | 2012 |
The immune-related role of BRAF in melanoma S Tomei, D Bedognetti, V De Giorgi, M Sommariva, S Civini, J Reinboth, ... Molecular oncology 9 (1), 93-104, 2015 | 35 | 2015 |
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools-a compass in the land of biomarker discovery D Bedognetti, JM Balwit, E Wang, ML Disis, CM Britten, LG Delogu, ... Journal of translational medicine 9, 1-21, 2011 | 35 | 2011 |
Evaluation of methods for the extraction of microbial DNA from vaginal swabs used for microbiome studies V Mattei, S Murugesan, M Al Hashmi, R Mathew, N James, P Singh, ... Frontiers in Cellular and Infection Microbiology 9, 197, 2019 | 34 | 2019 |
The stable traits of melanoma genetics: an alternate approach to target discovery TL Spivey, V De Giorgi, Y Zhao, D Bedognetti, Z Pos, Q Liu, S Tomei, ... BMC genomics 13, 1-11, 2012 | 31 | 2012 |
Molecular characterization of low grade and high grade bladder cancer A Apollo, V Ortenzi, C Scatena, K Zavaglia, P Aretini, F Lessi, ... PLoS One 14 (1), e0210635, 2019 | 29 | 2019 |
Temple-baraitser syndrome and zimmermann-laband syndrome: one clinical entity? A Mégarbané, R Al-Ali, N Choucair, M Lek, E Wang, M Ladjimi, CM Rose, ... BMC medical genetics 17, 1-11, 2016 | 29 | 2016 |
A molecular computational model improves the preoperative diagnosis of thyroid nodules S Tomei, I Marchetti, K Zavaglia, F Lessi, A Apollo, P Aretini, G Di Coscio, ... BMC cancer 12, 1-10, 2012 | 28 | 2012 |
c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules S Tomei, C Mazzanti, I Marchetti, L Rossi, K Zavaglia, F Lessi, A Apollo, ... Journal of translational medicine 10, 1-9, 2012 | 27 | 2012 |